South Korea‘s Ministry of Food and Drugs Safety (MFDS) has approved the Meere Company’s Revo-i, the first indigenous surgical robot system. Revo-i is helps surgeons perform general endoscopic surgery, a procedure that uses cameras or sensors to diagnose or treat conditions through small incisions or natural body openings. The system has four robotic arms that are controlled by the surgeon and an imaging system that provides three-dimensional images. At least one of the robotic arms is inserted into the body through a small incision and the surgeon uses the system to find the body part that will be treated.
Though robots in surgical procedures is nothing new, the emergence of a domestically produced, competitively priced robot from South Korea is a clear indicator that the field is about to enter a rapid growth phase. The medical robot market is currently worth $5.2 billion and will rise to $8.86 billion before the year within the next five years.
Although some surgical robots have minor roles such as guiding physicians to surgical sites and cutting bones for knee and hip replacement procedures–like Stryker or Robodoc, two machines have been certified by the MFDS for complicated procedures like endoscopic surgery. The minimally invasive surgery MIS( benefits patients, hospitals, and caregivers with shorter operative times, minimal blood loss, and reduced hospitalization time, all of which lead to lower hospital bills. The fact that Revo-i is being positioned to take on the market leader in surgical robots, US-based Intuitive Surgical, the maker of the Da Vinci surgical system.
Revo-i Surgical Robot
Source: Robb the Robot Guy